Bioprocess,Clinical Development,R&D,Weekly Roundups

Weekly News Round-up – 9/3/20

Proventa International Weekly News 4 years ago By Josh Neil
Proventa International Weekly News

In the news this week, everyone’s talking about this thing called ‘coronavirus’, not sure if you’ve heard of it. Gilead are set to donate 1.5 million doses of remdesivir to sick patients, while the Gates Foundation is preparing to spend ‘billions’ setting up factories for the most promising vaccines. All that and much more in the 4-week anniversary of the now-familiar:  

Round-up Coronavirus Special

(Part 4)


GILEAD DONATING 1.5 MILLION DOSES OF REMDESIVIR TO PATIENTS – The EMA has cleared Gilead Science’s antiviral drug remdesivir for compassionate use. The company recently announced it will donate 1.5 million doses of the drug to 140,000 severely ill patients. Remdesivir, an anti-coronavirus drug, is also to be used for expanded access and clinical trials. Gilead has accelerated production time of the drug to six months from one year. 

BILL GATES TO SPEND BILLIONS REDUCING COVID-19 VAX PRODUCTION – The Bill and Melinda Gates Foundation will spend ‘billions’ to help pharma create a coronavirus vaccine. The Gates’ will ‘fund factories’ for the seven most promising candidates, with two ultimately picked for mass production. 

EU URGED TO LIFT DRUG EXPORT BANS – The head of the European Commission has requested EU Member States lift export bans on needed drugs to stop coronavirus. Half the EU’s countries, including France and Poland, instituted the bans. Now several other countries in the EU are reporting shortages for antibiotics, painkillers and hydroxychloroquine. The European Commission has recently issued non-binding guidance on handling drug supplies.

In other news: 

R&D
Amgen and Adaptive co-ordinate to create antibodies to treat yearly coronavirus

Clinical Trials
FDA extends PDUFA review of Roche’s risdiplam SMA treatment

Manufacturing
Methadone can be supplied without new prescription during coronavirus pandemic

GSK and AstraZeneca to collaborate on new Covid-19 testing centre

That’s all for now. See you next week!

Joshua Neil, Editor
Proventa International

To ensure you remain up-to-date on the latest in clinical development, sign up for Proventa International’s online Clinical Operations, Supply Chain & Pharmacovigilance Strategy Meeting 2020.

More news

Role of an Immunologist: Exploring the Responsibilities

In the intricate web of human health, the immune system stands as a vigilant guardian, tirelessly defending against potential threats. At the forefront of understanding, deciphering, and harnessing the immune system's power is the immunologist. This article delves into the...

9 months ago
Bioprocess,Clinical Development,R&D,Weekly Roundups

Role of an Immunologist: Exploring the Responsibilities

In the intricate web of human health, the immune system stands as a vigilant guardian, tirelessly defending against potential threats. At the forefront of understanding, deciphering, and harnessing the immune system's power is the immunologist. This article delves into the...

9 months ago

Improving Warehouse Efficiency: The Role of Technology and Best Practices

In the fast-paced world of supply chain management, warehouse efficiency plays a pivotal role in ensuring timely and accurate order fulfillment while minimizing costs. With the rising demands of e-commerce and globalization, businesses are continually seeking innovative ways to optimize...

9 months ago
Bioprocess,Clinical Development,R&D,Weekly Roundups

Improving Warehouse Efficiency: The Role of Technology and Best Practices

In the fast-paced world of supply chain management, warehouse efficiency plays a pivotal role in ensuring timely and accurate order fulfillment while minimizing costs. With the rising demands of e-commerce and globalization, businesses are continually seeking innovative ways to optimize...

9 months ago

How to Reduce the Cost of Clinical Trial Supply Chain While Maintaining Quality and Efficiency

Clinical trial supply chain is a critical component of drug development, ensuring that drugs are available for testing, regulatory approval, and distribution. However, managing this supply chain can be challenging, with factors such as cost, quality, and efficiency all coming...

1 year ago
Bioprocess,Clinical Development,R&D,Weekly Roundups

How to Reduce the Cost of Clinical Trial Supply Chain While Maintaining Quality and Efficiency

Clinical trial supply chain is a critical component of drug development, ensuring that drugs are available for testing, regulatory approval, and distribution. However, managing this supply chain can be challenging, with factors such as cost, quality, and efficiency all coming...

1 year ago